Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Change in Cash (2020 - 2025)

GoHealth's Change in Cash history spans 6 years, with the latest figure at -$3.5 million for Q3 2025.

  • For Q3 2025, Change in Cash fell 116.42% year-over-year to -$3.5 million; the TTM value through Sep 2025 reached -$3.5 million, down 137.76%, while the annual FY2024 figure was -$49.9 million, 167.1% down from the prior year.
  • Change in Cash for Q3 2025 was -$3.5 million at GoHealth, down from $13.4 million in the prior quarter.
  • Across five years, Change in Cash topped out at $139.2 million in Q3 2022 and bottomed at -$198.9 million in Q4 2022.
  • The 5-year median for Change in Cash is $1.0 million (2023), against an average of -$5.9 million.
  • The largest annual shift saw Change in Cash tumbled 23032.44% in 2022 before it surged 1992.18% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$860000.0 in 2021, then crashed by 23032.44% to -$198.9 million in 2022, then soared by 132.38% to $64.4 million in 2023, then tumbled by 91.63% to $5.4 million in 2024, then tumbled by 165.15% to -$3.5 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Change in Cash are -$3.5 million (Q3 2025), $13.4 million (Q2 2025), and -$18.8 million (Q1 2025).